Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04862247 · ClinicalTrials.gov registry record · NA
Online Relapse Prevention Study
A NA study, sponsored by University of Louisville.
- Completed
- Registry status
- NA
- Development phase
- 130
- Enrollment target
NCT04862247 is a NA study that has completed, run by University of Louisville. The registered enrollment target is 130 participants.
The verdict
NCT04862247, a NA study, has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- NA
- Development phase
- 130 participants
- Enrollment target
Study Summary
The purpose of this study is to collect preliminary data on the feasibility and acceptability of the randomization of two relapse-prevention treatment conditions after discharge from intensive eating disorder (ED) treatment: an imaginal exposure therapy and a writing and thinking intervention. The second aim to test for (a) differences between the two treatments for the prevention of relapse and (b) preliminary change on clinical ED outcomes (e.g., ED symptoms, fears). The investigators further aim to examine the two treatments target fear extinction and if fear extinction is associated with ED outcomes. The investigators also plan to test if baseline differences in fear conditioning relate to change in ED outcomes across treatment.
Interventions
- BEHAVIORAL Imaginal Exposure Condition
- BEHAVIORAL Writing and Thinking Condition
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2021-06-04 |
| Est. Completion | 2025-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04862247
The ClinicalTrials.gov registry entry for NCT04862247 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Imaginal Exposure Condition is the first listed.
NCT04862247 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04862247 about?
NCT04862247 is a clinical study titled "Online Relapse Prevention Study". The purpose of this study is to collect preliminary data on the feasibility and acceptability of the randomization of two relapse-prevention treatment conditions after discharge from intensive eating disorder (ED) treatment: an imaginal exposure therapy and a writing and thinking intervention. The s...
What is the current status of trial NCT04862247?
This trial is currently completed. It is a NA study. The enrollment target is 130 participants. The study started on 2021-06-04. Estimated completion is 2025-02-01.
What interventions are being tested in trial NCT04862247?
The interventions under investigation include: Imaginal Exposure Condition (BEHAVIORAL), Writing and Thinking Condition (BEHAVIORAL).
Who is sponsoring clinical trial NCT04862247?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.